Hana Park

Prof. Hana Park

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Cancers
Verified
Journal Article
Open access
PDF file
YCYoung Eun Chon
Young Eun Chon
HPHana Park
Hana Park
HHHye Kyung Hyun
Hye Kyung Hyun
YHYeonjung Ha
Yeonjung Ha
MKMi Na Kim
Mi Na Kim
JPJun Yong Park
Jun Yong Park
The neutrophil-to-lymphocyte ratio (NLR) has recently been reported to predict the prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the survival of patients with HCC undergoing transarterial chemoembolization (TACE), and developed a predictive model. In total, 1697 patients with HCC undergoing TACE as first-line therapy at two university hospitals were enrolled (derivation set n = 921, internal validation set n = 395, external validation set n = 381). The tumor size, tumor number, AFP level, vascular invasion, Child–Pugh score, objective response after TACE, and NLR, selected as predictors of overall survival (OS) via multivariate Cox’s regression model, were incorporated into a 14-point risk prediction model (SNAVCORN score). The time-dependent areas under the receiver-operating characteristic curves for OS at 1, 3, and 5 years predicted by the SNAVCORN score were 0.812, 0.734, and 0.700 in the derivation set. Patients were stratified into three risk groups by SNAVCORN score (low, 0–4; intermediate, 5–9; high, 10–14). Compared with the low-risk group, the intermediate-risk (HR 3.10, p < 0.001) and high-risk (HR 7.37, p < 0.001) groups exhibited significantly greater mortality. The prognostic performance of the SNAVCORN score including NLR in patients with HCC treated with TACE was remarkable, much better than those of the conventional scores. The SNAVCORN score will guide future HCC treatment decisions.

15 November 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
SSSeung Kak Shin
Seung Kak Shin
IJIjin Joo
Ijin Joo
DSDo Seon Song
Do Seon Song
Jeong Won JangJeong Won Jang
Jeong Won Jang
JPJoong-Won Park
Joong-Won Park
Hana Park, Seung Kak Shin, Ijin Joo, Do Seon Song, Jeong Won Jang, and Joong-Won Park. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19163

30 January 2020 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SPSoo-Kyung Park
Soo-Kyung Park
CCChang Hwan Choi
Chang Hwan Choi
JCJaeyoung Chun
Jaeyoung Chun
HLHeeyoung Lee
Heeyoung Lee
EKEun-Sun Kim
Eun-Sun Kim
IDIBD Research Group of the Korean Association for the Study of Intestinal Diseases
IBD Research Group of the Korean Association for the Study of Intestinal Diseases
The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.

25 April 2025 in Gut and Liver
Verified
Journal Article
Open access
PDF file
SBSuh Eun Bae
Suh Eun Bae
KCKee Don Choi
Kee Don Choi
JCJaewon Choe
Jaewon Choe
MLMin Jung Lee
Min Jung Lee
SKSeon-Ok Kim
Seon-Ok Kim
HJHwoon-yong Jung
Hwoon-yong Jung
Suh Eun Bae, Kee Don Choi, Jaewon Choe, Min Jung Lee, Seonok Kim, Ji Young Choi, Hana Park, Jaeil Kim, Hye Won Park, Hye-Sook Chang, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240494

18 July 2025 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
JLJI YOUNG LEE
JI YOUNG LEE
SPSungwon Park
Sungwon Park
HLHyo Jeong Lee
Hyo Jeong Lee
SBSuh Eun Bae
Suh Eun Bae
JSJu Hyun Shim
Ju Hyun Shim
Hana Park, Ji Young Lee, Sungwon Park, Hyo Jeong Lee, Suh Eun Bae, Jaeil Kim, Hye-Sook Chang, Jaewon Choe, Hye Won Park, Ju Hyun Shim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250053

3 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
JKJeong Hwan Kim
Jeong Hwan Kim
WCWon Hyeok Choe
Won Hyeok Choe
SKSo Young Kwon
So Young Kwon
JKJeong Han Kim
Jeong Han Kim
ISIn-Kyung Sung
In-Kyung Sung
Background/Objectives: The role of endoscopic ultrasonography (EUS) in surveillance after endoscopic variceal ligation (EVL) for primary prophylaxis of esophageal variceal hemorrhage remains uncertain. This study compared the predictive value of high-frequency intraluminal ultrasound (HFIUS) and esophagogastroduodenoscopy (EGD) for subsequent variceal hemorrhage after prophylactic EVL. Methods: In this retrospective study, follow-up EGD and HFIUS were performed in 40 patients with liver cirrhosis who underwent EVL as primary prophylaxis against variceal hemorrhage. EGD-based variceal grade and variceal cross-sectional area (CSA) measured by HFIUS were compared in all 40 patients. Among them, 31 who achieved variceal eradication or reduction to grade 0/1 on surveillance EGD were subsequently followed to evaluate subsequent variceal hemorrhage and clinical outcomes. Results: Spearman’s correlation analysis revealed a statistically significant yet weak positive correlation between EGD-based variceal grade and variceal CSA measured by HFIUS (ρ = 0.347, p = 0.028). Among the 31 patients with grade 0/1 varices on follow-up EGD, the mean follow-up duration was 32.4 ± 8.8 months, during which variceal hemorrhage occurred in seven patients and five patients died. In this exploratory analysis based on seven hemorrhagic events, a preliminary variceal CSA cutoff of 9.8 mm2 predicted subsequent hemorrhage with an apparent sensitivity of 85.7% and specificity of 91.7% (optimism-corrected 75.3% and 90.0%; bootstrap-corrected AUC 0.945). Multivariate analysis showed that variceal CSA measured by HFIUS was independently associated with variceal hemorrhage (OR, 1.302; 95% CI, 1.040–2.020; p = 0.016), whereas EV grade assessed by surveillance EGD was not predictive of variceal hemorrhage. Conclusions: HFIUS-derived variceal CSA was associated with subsequent hemorrhage among patients with grade 0/1 varices after EVL and may provide prognostic information not captured by endoscopic grade alone. Incorporation of HFIUS-based EUS into post-EVL surveillance may help identify patients at persistent bleeding risk who may benefit from intensified prophylactic strategies, even when grade 0/1 eradication has been confirmed on surveillance EGD. Given the small number of events, the proposed cutoff is preliminary and requires external validation.